Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the Company designs, manufactures, and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The Company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The Company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The Company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia Pacific.
Company profile
Ticker
IVCRQ
Exchange
Website
CEO
Matthew Monaghan
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Edwards Lifesciences • Avanos Medical • MSA Safety • Align Technology • Surgalign • RTI Surgical ...
Former names
INVACARE CORP
SEC CIK
Corporate docs
Subsidiaries
Adaptive Switch Laboratories, Inc. • Alber GmbH • Invacare Logistics GmbH • Carroll Healthcare General Partner Inc. • Carroll Healthcare Inc. • Freedom Designs, Inc. • Invacare AB • Invacare AG • Invacare A/S • Invacare AS, a Norwegian company. ...
IRS number
952680965
IVCRQ stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
15 Mar 24
8-K
Departure of Directors or Certain Officers
7 Mar 24
8-K
Entry into a Material Definitive Agreement
1 Mar 24
8-K
Departure of Directors or Certain Officers
16 Feb 24
NT 10-Q
Notice of late quarterly filing
15 Nov 23
8-K
Changes in Registrant's Certifying Accountant
13 Sep 23
8-K
Entry into a Material Definitive Agreement
7 Sep 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
EFFECT
Notice of effectiveness
3 Aug 23
8-K
Invacare Holdings Corporation Names Kai Zhu Senior Vice President and Chief Financial Officer
26 Jun 23
Transcripts
IVCRQ
Earnings call transcript
2022 Q3
12 Nov 22
IVCRQ
Earnings call transcript
2022 Q2
9 Aug 22
IVCRQ
Earnings call transcript
2022 Q1
14 May 22
IVCRQ
Earnings call transcript
2021 Q4
9 Mar 22
IVCRQ
Earnings call transcript
2021 Q3
28 Oct 21
IVCRQ
Earnings call transcript
2021 Q2
8 Aug 21
IVCRQ
Earnings call transcript
2021 Q1
9 May 21
IVCRQ
Earnings call transcript
2020 Q4
11 Feb 21
IVCRQ
Earnings call transcript
2020 Q3
30 Oct 20
IVCRQ
Earnings call transcript
2020 Q2
8 Aug 20
Latest ownership filings
SC 13D/A
SILVERBACK ASSET MANAGEMENT LLC
15 Mar 24
SC 13D/A
TENOR CAPITAL MANAGEMENT Co., L.P.
15 Mar 24
SC 13D/A
DG Capital Management, LLC
15 Mar 24
4
Change in insider ownership
15 Mar 24
4
Change in insider ownership
15 Mar 24
4
Dov Gertzulin
15 Mar 24
SC 13D/A
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP
15 Mar 24
4
ANTHONY ALEXANDER YOSELOFF
15 Mar 24
SC 13D/A
Rosen Steven H
6 Mar 24
3
Carney Hawks
23 Feb 24
Financial summary
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 66.28 mm | 66.28 mm | 66.28 mm | 66.28 mm | 66.28 mm | 66.28 mm |
Cash burn (monthly) | (no burn) | (no burn) | 13.41 mm | 9.61 mm | 10.20 mm | 9.46 mm |
Cash used (since last report) | n/a | n/a | 159.92 mm | 114.63 mm | 121.67 mm | 112.84 mm |
Cash remaining | n/a | n/a | -93.64 mm | -48.34 mm | -55.39 mm | -46.55 mm |
Runway (months of cash) | n/a | n/a | -7.0 | -5.0 | -5.4 | -4.9 |
Institutional ownership, Q4 2023
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 1 |
Closed positions | 3 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 54.51 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Endurant Capital Management | 39.49 mm | $0.00 |
Rosen Steven H | 15.02 mm | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Mar 24 | Davidson Kempner Capital Management | Common Stock, par value $0.001 per share ("Common Stock") | Other | Acquire J | Yes | No | 0 | 1,404,736 | 0.00 | 2,122,386 |
13 Mar 24 | TENOR CAPITAL MANAGEMENT | Common Stock | Other | Acquire J | Yes | No | 0 | 2,114,876 | 0.00 | 3,167,931 |
13 Mar 24 | DG Capital Management | Common Stock | Other | Acquire J | Yes | No | 0 | 4,182,724 | 0.00 | 6,319,518 |
13 Mar 24 | Silverback Asset Management | Common Stock | Other | Acquire J | Yes | No | 0 | 2,705,409 | 0.00 | 4,052,547 |